Clinical Trials Directory

Trials / Conditions / Toxoplasmosis

Toxoplasmosis

14 registered clinical trials studyying Toxoplasmosis — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingRole of Circulating MicroRNAs in Differentiating Psychological Disorders Among Women With Chronic Toxoplasmosi
NCT07346833
Benha University—
Not Yet RecruitingIsolated Positive Toxoplasma Gondii PCR in Blood
NCT07054918
University Hospital, Clermont-Ferrand—
RecruitingPrognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosi
NCT06305468
Assistance Publique - Hôpitaux de Paris—
CompletedAnalysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
NCT07044037
Centre Hospitalier de Saint-Denis—
UnknownToxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies
NCT05963295
Sohag UniversityN/A
UnknownMeasuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences
NCT05860998
University of Zurich—
UnknownEvaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris
NCT05783778
Sohag UniversityN/A
CompletedDiagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
NCT04825600
Centre Hospitalier Universitaire de NiceN/A
WithdrawnLatent Toxoplasmosis in Females With Borderline Personality Disorder
NCT03932656
Marie Ociskova—
CompletedPrevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART
NCT03993093
Singh, Ranjan Kumar, M.D.—
CompletedPhase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects
NCT03258762
GlaxoSmithKlinePhase 1
CompletedPilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia
NCT02011750
University of PittsburghPhase 4
CompletedAntiretroviral Drug Interaction Study in Volunteers With HIV
NCT01479361
National Institutes of Health Clinical Center (CC)Phase 1
RecruitingPyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
NCT00004317
National Institute of Allergy and Infectious Diseases (NIAID)Phase 4